BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23134012)

  • 21. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.
    Blom A; Beylot-Barry M; D'Incan M; Laroche L
    J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous lymphomas].
    Ingen-Housz-Oro S; Bagot M
    Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted therapies for cutaneous T-cell lymphomas.
    Kaplan JB; Guitart J; Giles FJ
    Expert Rev Hematol; 2014 Aug; 7(4):481-93. PubMed ID: 25025372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 30. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30
    Pujol RM; Gallardo F
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):14-23. PubMed ID: 32896500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome.
    Querfeld C; Zain J; Rosen ST
    Cancer Treat Res; 2019; 176():225-248. PubMed ID: 30596221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous T-cell lymphoma bullosa: 2 cases].
    Héliot I; Beylot-Barry M; Vergier B; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2003; 130(6-7):639-42. PubMed ID: 13679703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous T-cell lymphoma (mycosis fungoides).
    Lorincz AL
    Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
    [No Abstract]   [Full Text] [Related]  

  • 34. A primary care approach to cutaneous T-cell lymphoma.
    Macey WH
    Nurse Pract; 2000 Apr; 25(4):82, 85-8, 91-4 passim. PubMed ID: 10790799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous panniculitis-like T cell lymphoma presented as erythema nodosum: A case report.
    Sun D; Zheng S; Hong YX; Chen HD; Gao XH
    Dermatol Ther; 2021 Jan; 34(1):e14572. PubMed ID: 33219732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
    Dummer R; Foss F; Dreno B; Bagot M
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 38. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
    Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
    [No Abstract]   [Full Text] [Related]  

  • 39. Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.
    Lazaridou I; Ram-Wolff C; Bouaziz JD; Bégon E; Battistella M; Rivet J; Jachiet M; Bagot M; de Masson A
    Acta Derm Venereol; 2020 Sep; 100(16):adv00271. PubMed ID: 32556342
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment considerations in case of subcutaneous panniculitis like T cell lymphoma with hemophagocytic syndrome.
    Khemani UN; Pardeshi SS
    Dermatol Ther; 2021 Mar; 34(2):e14742. PubMed ID: 33404186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.